175 related articles for article (PubMed ID: 19342206)
1. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Avital A; Gross-Isseroff R; Stryjer R; Hermesh H; Weizman A; Shiloh R
Eur Neuropsychopharmacol; 2009 Jul; 19(7):476-82. PubMed ID: 19342206
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
Gross-Isseroff R; Magen A; Shiloh R; Hermesh H; Weizman A
Int Clin Psychopharmacol; 2005 Jan; 20(1):23-5. PubMed ID: 15602112
[TBL] [Abstract][Full Text] [Related]
4. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
[TBL] [Abstract][Full Text] [Related]
5. Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Fischel T; Hermesh H; Aizenberg D; Zemishlany Z; Munitz H; Benjamini Y; Weizman A
J Clin Psychopharmacol; 2001 Dec; 21(6):612-5. PubMed ID: 11763011
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
[TBL] [Abstract][Full Text] [Related]
7. Propranolol as a primary treatment of neuroleptic-induced akathisia.
Irwin M; Sullivan G; Van Putten T
Hillside J Clin Psychiatry; 1988; 10(2):244-50. PubMed ID: 2906317
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia.
Wells BG; Cold JA; Marken PA; Brown CS; Chu CC; Johnson RP; Nasdahl CS; Ayubi MA; Knott DH; Arheart KL
J Clin Psychiatry; 1991 Jun; 52(6):255-60. PubMed ID: 1676029
[TBL] [Abstract][Full Text] [Related]
9. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
[TBL] [Abstract][Full Text] [Related]
11. Lack of efficacy of d-propranolol in neuroleptic-induced akathisia.
Adler LA; Angrist B; Fritz P; Rotrosen J; Mallya G; Lipinski JF
Neuropsychopharmacology; 1991 Feb; 4(2):109-15. PubMed ID: 1673844
[TBL] [Abstract][Full Text] [Related]
12. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
[TBL] [Abstract][Full Text] [Related]
13. Patient preference for triptan formulations: a prospective study with zolmitriptan.
Dowson A; Bundy M; Salt R; Kilminster S
Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
Kramer MS; Gorkin R; DiJohnson C
Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
[TBL] [Abstract][Full Text] [Related]
15. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen.
Evers S; Rahmann A; Kraemer C; Kurlemann G; Debus O; Husstedt IW; Frese A
Neurology; 2006 Aug; 67(3):497-9. PubMed ID: 16775229
[TBL] [Abstract][Full Text] [Related]
16. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
17. Role of mirtazapine in the treatment of antipsychotic-induced akathisia.
Hieber R; Dellenbaugh T; Nelson LA
Ann Pharmacother; 2008 Jun; 42(6):841-6. PubMed ID: 18460588
[TBL] [Abstract][Full Text] [Related]
18. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
[TBL] [Abstract][Full Text] [Related]
20. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis.
Adler LA; Peselow E; Rosenthal M; Angrist B
Psychopharmacol Bull; 1993; 29(2):283-6. PubMed ID: 8290678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
